Table 4. Pearson correlation analysis of early-phase plasma and hepatic miR-1246 with Aspartate transaminase (AST) and Alanine Aminotransferase (ALT) in liver transplantation of HCC patients.
Time points after liver transplantation (Day) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre-LT | Day 0 | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | Day 14 | |||
Early-phase plasma miR-1246 level (Log2) | AST (u/l) | Correlation | 0.007 | 0.314 | 0.259 | 0.286 | 0.325 | 0.249 | 0.087 | 0.149 | 0.142 | 0.085 |
P | 0.956 | 0.013* | 0.042* | 0.025* | 0.010* | 0.051 | 0.499 | 0.249 | 0.271 | 0.662 | ||
Number | 62 | 62 | 62 | 61 | 62 | 62 | 62 | 62 | 62 | 29 | ||
ALT (u/l) | Correlation | −0.035 | 0.378 | 0.341 | 0.361 | 0.377 | 0.388 | 0.295 | 0.303 | 0.241 | 0.232 | |
P value | 0.790 | 0.002** | 0.007** | 0.004** | 0.002** | 0.002** | 0.020* | 0.017* | 0.059 | 0.226 | ||
Number | 62 | 62 | 62 | 61 | 62 | 62 | 62 | 62 | 62 | 29 | ||
Early-phase hepatic miR-1246 level (Log2) | AST (u/l) | Correlation | −0.093 | 0.255 | 0.321 | 0.287 | 0.168 | 0.168 | 0.126 | 0.108 | 0.057 | 0.043 |
P | 0.502 | 0.062 | 0.018* | 0.037* | 0.224 | 0.224 | 0.362 | 0.436 | 0.685 | 0.843 | ||
Number | 54 | 54 | 54 | 53 | 54 | 54 | 54 | 54 | 54 | 24 | ||
ALT (u/l) | Correlation | −0.069 | 0.261 | 0.300 | 0.290 | 0.245 | 0.262 | 0.275 | 0.244 | 0.147 | 0.253 | |
P | 0.620 | 0.056 | 0.028* | 0.035* | 0.075 | 0.056 | 0.044* | 0.075 | 0.290 | 0.233 | ||
Number | 54 | 54 | 54 | 53 | 54 | 54 | 54 | 54 | 54 | 24 |
p<0.05;
p<0.01.